Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Marie Vétizou, Jonathan M. Pitt, Romain Daillère, +35

Science

Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

Denarda Dangaj Laniti, Marine Bruand, Alizée J Grimm, +24

Cancer Cell

Tumor ImmunologyCancer ImmunosurveillanceSolid TumorsImmunologyTumor Immunity +7

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

Romain Daillère, Marie Vétizou, Nadine Waldschmitt, +33

Immunity

Health SciencesMucosal ImmunologyPathogenesisImmunologyEnterococcus Hirae +7

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Benjamin Besse, Mélinda Charrier, Valérie Lapierre, +25

OncoImmunology

ImmunologyImmunotherapeuticsImmunotherapyFirst Line ChemotherapyTumor Immunology +18

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

Erika Vacchelli, Yuting Ma, Elisa Elena Baracco, +39

Science

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Nicolas F. Delahaye, Sylvie Rusakiewicz, Isabelle Martins, +38

Nature Medicine

OncologyGastrointestinal OncologyMedicineImmunologyPathology +6

Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

Sylvie Rusakiewicz, Michaëla Semeraro, Matthieu Sarabi, +29

Cancer Research

T-regulatory CellImmunologyGastroenterologyPathologyNk Cells +18

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni, +20

Annals of Oncology

Predictors of responses to immune checkpoint blockade in advanced melanoma

Nicolas Jacquelot, María P. Roberti, David Enot, +47

Nature Communications

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

Jaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, +33

Cancer Cell

Tumor ImmunologyAntitumor T CellsCancer ImmunosurveillanceImmunologyCd28 Costimulation +7